| ORIGINAL ARTICLE |
|
| Year : 2014 | Volume
: 32
| Issue : 1 | Page : 44-48 |
Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore
N Pahwa1, R Kumar2, S Nirkhiwale3, A Bandi4
1 Department of Nephrology, Department of laboratory medicine, greater Kailash Hospital, Indore, India
2 Central Research Laboratory, Sri Aurobindo Institute of Medical Sciences, Indore, India
3 Department of Laboratory Medicine, Greater Kailash Hospital, Indore, Madhya Pradesh, India
4 Department of Urology, Greater Kailash Hospital, Indore, Madhya Pradesh, India
Correspondence Address:
S Nirkhiwale
Department of Laboratory Medicine, Greater Kailash Hospital, Indore, Madhya Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0255-0857.124300
Background: The incidence of fungal infections has increased significantly, contributing to morbidity and mortality. This is caused by an alarming increase in infections with multi-drug resistant bacteria leading to overuse of broad-spectrum antimicrobials, which lead to overgrowth of Candida, thus enhancing its opportunity to cause disease. Candida are major human fungal pathogens that cause both mucosal and deep tissue infections. Objective : The aim of our study was to identify the distribution of Candida species among clinical isolates and their sensitivity pattern for common antifungal drugs. Materials and Methods : Two hundred and thirty-seven different clinical isolates of Candida were collected from patients visiting to a tertiary care centre of Indore from 2010 to 2012. Identification of Candida species as well as antifungal sensitivity testing was performed with Vitek2 Compact (Biomerieux France) using vitek 2 cards for identification of yeast and yeast like organisms (ID-YST cards). Antifungal susceptibility testing was performed with Vitek2 "Fungal Susceptibility Card (AST YS01) kits respectively. Results : We found that the non-albicans Candida were more prevalent than Candida albicans in paediatric (<3 year) and older (>60 year) patients than other age group (4-18, 19-60 years) patients and also in intensive care unit (ICU) patients as compared to out patient department (OPD) patients. Resistance rates for amphotericin B, fluconazole, flucytosine, itraconazole, and voriconazole were 2.9%, 5.9%, 0.0%, 4.2% and 2.5%%, respectively. All the strains of C. krusei were found resistant to fluconazole with intermediate sensitivity to flucytosine. Conclusion: Species-level identification of Candida and their antifungal sensitivity testing should be performed to achieve better clinical results.
[FULL TEXT] [PDF]*
|
